EPDR1 and breast cancer: The miR-181a-5p was predicted to be a potential binding site for EPDR1 mRNA (Fig. 3B), which is highly expressed in BC (Fig. 3C) and has a poor prognosis in BC patients with high expression (Fig. 3D).